PHS
VRAY

PFM Health Sciences’s ViewRay, Inc. VRAY Stock Holding History

PFM Health Sciences’s Portfolio VRAY Stock Details VRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,114,316
Closed -$12.8M – 119
2018
Q4 		$12.8M Buy
2,114,316
+1,234,870
+140% +$9.25M 0.34% 67
2018
Q3 		$8.23M Buy
+879,446
New +$8.64M 0.12% 105

Other funds holding VRAY

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

PFM Health Sciences's VRAY Position: Q1 2019 in Review

PFM Health Sciences sold out of ViewRay, Inc. (VRAY) in Q1 2019, closing a stake of 2,114,316 shares — an estimated $12.8M sold.

PFM Health Sciences first reported a position in VRAY in Q3 2018 and held it in 2 quarters. The position peaked at $12.8M in Q4 2018. 144 funds tracked by Wall St. Rank hold VRAY as of Q1 2019.

  • PFM Health Sciences reported no remaining ViewRay, Inc. position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 2,114,316 ViewRay, Inc. shares in Q1 2019, an estimated $12.8M.
  • PFM Health Sciences first reported a position in ViewRay, Inc. in Q3 2018 and held it in 2 quarters.
  • PFM Health Sciences's ViewRay, Inc. position peaked at $12.8M in Q4 2018.
  • 144 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.